Sorted By:

Relevance


PhRMA to Present the 2017 Research & Hope Awards for Outstanding Mental Health Advocacy and Research

PhRMA  |  Press Release

To learn more about the Research and Hope Award winners, please visit: www.PhRMA.org/event/Research-and-Hope-Awards-2017 To learn more about the GOBOLDLY campaign and view the Together ads, please visit: www.GoBoldly.com/Together “Medicines in Development for Mental Illness” can be downloaded at: www.PhRMA.org/report/Medicines-in-Development-for-Mental-Illnesses-2017-Report About PhRMAThe Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives.
https://www.phrma.org/press-release/phrma-to-present-the-2017-research-and-hope-awards-for-outstanding-mental-health-advocacy-and-research

PhRMA Statement on Comments to CMS Regarding Proposed Part D Rule and RFI Exploring Pass-Through Rebates to Seniors at Point of Sale

PhRMA  |  Press Release

[2]- http://www.phrma.org/report/reducing-part-d-beneficiary-costs-through-point-of-sale-rebates “CMS proposes requiring plans to pass through a portion of the cost-weighted average rebate amount calculated at the therapeutic class or category-level.
https://www.phrma.org/press-release/phrma-statement-on-comments-to-cms-regarding-proposed-part-d-rule-and-rfi-exploring-pass-through-rebates-to-seniors-at-point-of-sale

Week in Review: The Latest from PhRMA

PhRMA  |  Blog Post

Learning and Action Network Kickoff Meeting – PhRMA has long supported policies to advance affordable, high-quality, individualized care, and we were pleased to participate in this week’s inaugural meeting of the Learning and Action Network (LAN), an initiative of HHS to discuss payment and delivery reform.
http://catalyst.phrma.org/week-in-review-the-latest-from-phrma-march-27-2015

PhRMA Statement on Prescription Medicine Cost Growth

PhRMA  |  Press Release

Industry-wide research and investment reached a record $65.2 billion in 2008.
https://www.phrma.org/press-release/phrma-statement-on-prescription-medicine-cost-growth

The Five Essential Truths about Prescription Drug Spending

PhRMA  |  Blog Post

And new hepatitis C therapies have cure rates above 90 percent and dramatically decrease the burden of the disease on the U.S. health care system and the economy.
http://catalyst.phrma.org/the-five-essential-truths-about-prescription-drug-spending

PhRMA CEO in Forbes - How to negotiate better deals for prescription medicines

PhRMA  |  Blog Post

We also need to reform outdated, unclear regulations that discourage companies from offering discounts that are tied to outcomes, rather than volume.
http://catalyst.phrma.org/phrma-ceo-in-forbes-how-to-negotiate-better-deals-for-prescription-medicines

PhRMA Calls for Repeal of the Ensuring Patient Access and Effective Drug Enforcement Act of 2016

PhRMA  |  Press Release

Contrary to media reports, PhRMA did not previously endorse the Ensuring Patient Access and Effective Drug Enforcement Act of 2016 or advocate for its enactment.
https://www.phrma.org/press-release/phrma-calls-for-repeal-of-the-ensuring-patient-access-and-effective-drug-enforcement-act-of-2016

Rick Dunetz

PhRMA  |  Biography

Prior to establishing his presence in the sport of volleyball, Rick worked in the technology industry where he mastered the art of data mining, still one of his favorite pastimes.
https://www.phrma.org/biography/rick-dunetz

Office of Accountability

PhRMA  |  From PhRMA

Read the latest report issued by the Office of Accountability.
https://www.phrma.org/media/office-of-accountability

Guest Post: The Clinical trial experience from a patient & researcher perspective

PhRMA  |  Blog Post

Clinical trials are often the last resort for patients although in the age of immunotherapies that is not now always the case. 
http://catalyst.phrma.org/guest-post-the-clinical-trial-experience-from-a-patient-researcher-perspective

Medicare Monday: How existing CMMI models affect Medicare Part B

PhRMA  |  Blog Post

Earlier this year the Center for Medicare & Medicaid Innovation (CMMI) proposed the Medicare Part B Drug Payment Model, also known as the Part B Demo, an experiment that would change how providers are reimbursed for their prescribing, utilization and treatment patterns within the Medicare Part B program.
http://catalyst.phrma.org/medicare-monday-how-existing-cmmi-models-affect-medicare-part-b

Sharing Negotiated Discounts Could Save Patients More than $800 Annually and Would Increase Premiums About 1 Percent

PhRMA  |  Press Release

View the full analysis here.
https://www.phrma.org/press-release/sharing-negotiated-discounts-could-save-patients-more-than-800-annually-and-would-increase-premiums-about-1-percent

PhRMA Kicks Off National Health Care Dialogue to Examine the New Era of Medicine

PhRMA  |  Press Release

Ubl will participate in an underwriter series one-on-one conversation with Joe Shortsleeve, Emmy award winning journalist and long-time anchor and investigative reporter at Boston’s WBZ.
https://www.phrma.org/press-release/phrma-kicks-off-national-health-care-dialogue-to-examine-the-new-era-of-medicine

Who gets a seat at ICER’s table? Hint: It’s not patients

PhRMA  |  Blog Post

Read more about PhRMA’s policy solutions to promote value-driven health care here.
http://catalyst.phrma.org/who-gets-a-seat-at-icers-table-hint-its-not-patients

PhRMA Foundation recognizes inaugural Challenge Award recipients

PhRMA  |  Blog Post

THIRD PLACE: Patient Report Outcome Measures to Advance a Value-Driven Health Care System, University of Michigan Patient reported outcome measures (PROMs) are tools that assess patient perspectives on their health without interpretation by any other parties, and they are key tools in clinical research.
http://catalyst.phrma.org/phrma-foundation-recognizes-inaugural-challenge-award-recipients

Government-imposed price controls threaten innovation and access

PhRMA  |  Blog Post

The Korean government institutes drastic price reductions on the off-patent and generics market, and then bases prices of new, innovative medicines on the weighted average price within that therapeutic class, which includes those now heavily discounted medicines.
http://catalyst.phrma.org/government-imposed-price-controls-threaten-innovation-and-access

More than 240 immuno-oncology treatments in development to fight cancer

PhRMA  |  Blog Post

To learn more about the “Medicines in Development for Immuno-Oncology” report click here.
http://catalyst.phrma.org/more-than-240-immuno-oncology-treatments-in-development-to-fight-cancer

STEM

PhRMA  |  From PhRMA

The report found that over the course of just five years, two dozen PhRMA-member companies supported more than 90 individual initiatives, reaching over 1.6 million students and 17,500 teachers across the U.S.
https://www.phrma.org/media/stem-growing-our-next-generation-of-innovators

Terry McAuliffe

PhRMA  |  Biography

Luke Catholic Church for two decades and have been involved in every sport, activity, and competition imaginable with their five children Dori, Jack, Mary, Sally, and Peter. 
https://www.phrma.org/biography/terry-mcauliffe

PhRMA Statement on Prescription Drug Importation - 2009

PhRMA  |  Press Release

Industry-wide research and investment reached a record $65.2 billion in 2008.
https://www.phrma.org/press-release/phrma-statement-on-prescription-drug-importation-2009

Medicare Monday: New study further confirms increased use of generics after Part D

PhRMA  |  Blog Post

In fact, in 2015, the use of generics increased to 86 percent, according to the Medicare Trustees report, up from 85 percent in 2014.
http://catalyst.phrma.org/medicare-monday-new-study-further-confirms-increased-use-of-generics-after-part-d

Why drug importation threatens patient safety

PhRMA  |  Blog Post

As CNN reported, quoting an online seller from Pakistan, “We sell all over the world, to America, Europe, China, Iran and Iraq.
http://catalyst.phrma.org/why-drug-importation-threatens-patient-safety

PhRMA, member companies and NIH create public-private partnership for immuno-oncology

PhRMA  |  Blog Post

As PhRMA reported in June, there are currently more than 240 immuno-oncology medicines and vaccines in development to help treat cancer.
http://catalyst.phrma.org/phrma-member-companies-and-nih-create-public-private-partnership-for-immuno-oncology

340B Spotlight: Program continues to grow with no end in sight

PhRMA  |  Blog Post

report-to-the-congress-overview-of-the-340b-drug-pricing-program.pdf?
http://catalyst.phrma.org/340b-spotlight-program-continues-to-grow-with-no-end-in-sight

Highlights from Tackling Diabetes: Solutions to a Complex Disease

PhRMA  |  Video

The discussion, led by The Hill’s National Correspondent Reid Wilson and Health Care Reporter Sarah Ferris, addressed how to stop the spread of this disease through policy initiatives and regulatory reforms and explore how the current landscape of diabetes care could be changed by a potential repeal of the Affordable Care Act.
https://www.phrma.org/video/highlights-from-tackling-diabetes-solutions-to-a-complex-disease

You have reviewed the first 350 results out of 1029. Each page contains 25 results. You're on page 14.

prev 13 14 15 16 17 18 next